(Q34418063)

2 August 2017

1 reference

title

Therapeutic intervention with inhibitors of co-stimulatory pathways in autoimmune disease (English)

1 reference

2 August 2017

1 reference

Aruffo A

1 reference

2 August 2017

Hollenbaugh D

series ordinal

1 reference

2 August 2017

publication date

1 December 2001

1 reference

Current Opinion in Immunology

2 August 2017

published in

1 reference

2 August 2017

1 reference

2 August 2017

1 reference

2 August 2017

page(s)

683-686

1 reference

Costimulatory regulation of T cell function.

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2801%2900279-5

7 January 2021

Information transfer at the immunological synapse.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2801%2900279-5

7 January 2021

The expanding world of co-stimulation: the two-signal model revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2801%2900279-5

7 January 2021

From synapses to immunological memory: the role of sustained T cell stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2801%2900279-5

7 January 2021

Adhesion domain of human T11 (CD2) is encoded by a single exon

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2801%2900279-5

7 January 2021

Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2801%2900279-5

7 January 2021

CTLA-4 and T cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2801%2900279-5

7 January 2021

CD28, CTLA-4 and their ligands: who does what and to whom?

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2801%2900279-5

7 January 2021

CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2801%2900279-5

7 January 2021

The LW blood group glycoprotein is homologous to intercellular adhesion molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2801%2900279-5

7 January 2021

Binding Sites of Leukocyte β2Integrins (LFA-1, Mac-1) on the Human ICAM-4/LW Blood Group Protein

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2801%2900279-5

7 January 2021

Intercellular adhesion molecule-4 binds alpha(4)beta(1) and alpha(V)-family integrins through novel integrin-binding mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2801%2900279-5

7 January 2021

T-cell receptor cross-linking transiently stimulates adhesiveness through LFA-1

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2801%2900279-5

7 January 2021

How LFA-1 binds to different ligands

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2801%2900279-5

7 January 2021

The leukocyte integrins

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2801%2900279-5

7 January 2021

Effects of administration of a single dose of a humanized monoclonal antibody to CD11a on the immunobiology and clinical activity of psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2801%2900279-5

7 January 2021

Very late antigen 4 (VLA4) antagonists as anti-inflammatory agents

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2801%2900279-5

7 January 2021

The effect of anti-alpha4 integrin antibody on brain lesion activity in MS. The UK Antegren Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2801%2900279-5

7 January 2021

T cells: A proliferation of costimulatory molecules.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2801%2900279-5

7 January 2021

Inhibition of p38 MAP kinase as a therapeutic strategy

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2801%2900279-5

7 January 2021

10.1016/S0952-7915(01)00279-5

Identifiers

DOI

1 reference

2 August 2017

1 reference